MARKET

AEON

AEON

Aeon Biopharma
AMEX
0.7151
+0.0201
+2.89%
After Hours: 0.6850 -0.0301 -4.21% 19:45 06/12 EDT
OPEN
0.7399
PREV CLOSE
0.6950
HIGH
0.7399
LOW
0.6900
VOLUME
56.20K
TURNOVER
--
52 WEEK HIGH
1.450
52 WEEK LOW
0.6252
MARKET CAP
18.81M
P/E (TTM)
-0.1719
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AEON last week (0601-0605)?
Weekly Report · 5d ago
AEON Biopharma Presents New Analytical And Functional Data Supporting Biosimilarity Of ABP-450 To BOTOX At 68th Annual Scientific Meeting Of AHS
Benzinga · 06/04 11:13
Weekly Report: what happened at AEON last week (0525-0529)?
Weekly Report · 06/01 10:07
Weekly Report: what happened at AEON last week (0518-0522)?
Weekly Report · 05/25 10:10
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 05/18 17:05
Weekly Report: what happened at AEON last week (0511-0515)?
Weekly Report · 05/18 10:09
AEON Biopharma GAAP EPS of -$0.29
Seeking Alpha · 05/15 09:04
AEON Biopharma Releases Updated Investor Relations Presentation
TipRanks · 05/14 20:50
More
About AEON
AEON Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing its botulinum toxin complex, ABP-450 (prabotulinumtoxinA) injection or ABP-450, for debilitating medical conditions, with an initial focus on the neuroscience market. ABP-450 is a 2-chain polypeptide, a heavy chain joined by a bond to a light chain. ABP-450 interferes with nerve impulses by inhibiting the release of acetylcholine into the neuromuscular junction, causing a flaccid paralysis of muscles. The active biologic ingredient in ABP-450 is Clostridium botulinum toxin, type A with a complete molecular complex weight of 900 kDa. Its initial development programs for ABP-450 are directed at migraine, cervical dystonia, gastroparesis and post-traumatic stress disorder (PTSD). The Company has completed enrollment and dosing of patients for a Phase II double blind study of ABP-450 for the treatment of both chronic and episodic migraine.

Webull offers Aeon Biopharma Inc stock information, including AMEX: AEON real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AEON stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AEON stock methods without spending real money on the virtual paper trading platform.